Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.941
+0.021 (1.09%)
At close: Nov 13, 2026, 4:00 PM EST
1.920
-0.021 (-1.08%)
After-hours: Nov 13, 2026, 7:30 PM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $1.23 million as of November 13, 2026. It is the 48,978th most valuable company in the world and the 6,566th biggest in the United States. Its market cap has decreased by 88.54% in one year.
Market Cap
1.23M
Enterprise Value
1.38M
1-Year Change
-88.54%
Global Rank
Country Rank
#6,566 United States
Category
ChartMarket Cap Chart
Since October 11, 2023, Propanc Biopharma's market cap has increased from $284.43K to $1.23M, an increase of 332.02%. That is a compound annual growth rate of 60.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.23M | -82.86% |
| Dec 31, 2025 | 7.17M | 4,254.83% |
| Dec 31, 2024 | 164.67K | -8.41% |
| Dec 29, 2023 | 179.79K | -36.79% |
| Oct 11, 2023 | 284.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 1.72M |
| 60 Degrees Pharmaceuticals | 1.72M |
| Aptevo Therapeutics | 1.66M |
| Enlivex | 1.57M |
| Kairos Pharma | 1.54M |
| PMGC Holdings | 1.28M |
| Onconetix | 1.23M |
| Endovia Health Sciences | 1.14M |